GYRE vs SNOW · rev $53.5M vs rev $1.55B
Gyre Therapeutics Inc. (GYRE) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy Ph.D..
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
GYRE currently screens at market cap $589.9M. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the GYRE and SNOW stock pages for the full models.
Not investment advice.